...
首页> 外文期刊>Srpski Arhiv za Celokupno Lekarstvo >Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks
【24h】

Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks

机译:在孕期11-13 + 6周通过孕产妇年龄,胎儿颈部半透明性和孕产妇血清生化筛选非整倍体

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction. Aneuploidies are the major cause of perinatal death and early psychophysical disorders. Objective. In this study, we analyzed detection and false-positive rates of screening for aneuploidies in the first trimester by the combination of maternal age, fetal nuchal translucency (NT) thickness and maternal serum free beta-human chorionic gonadotrophin (β-hCG), and pregnancy-associated plasma protein-A (PAPP-A) at 11-13+6 weeks of gestation, using the appropriate software developed by the Fetal Medicine Foundation. Methods. Our screening study for aneuploidies analyzed 4172 singleton pregnancies from January 2006 to December 2010. The sensitivities and false-positive rates using the combined aneuploidies determination for the risk cut-off of 1:275 were evaluated. Results. In the trisomy 21 pregnancies, the fetal NT was higher than 95th centile, in 72.8%, serum free b-hCG concentration it was above the 95th centile in 55% and serum PAPP-A was below the 5th centile in 47% of the cases. In the trisomy 18 and 13, the fetal NT was above 95th centile in 66.6% and 44.4% of the cases, respectively. The serum free b-hCG concentration was above the 95th centile in 0 and 10%, but serum PAPP-A was below 5th centile in 80.9% and 88.8% of pregnancies. In the trisomy 21 pregnancies the median free beta-hCG was 2.3 MoM and the median PAPP-A was 0.45 MoM. Chromosomal abnormalities were detected in 169 fetuses: trisomy 21 (97), Turner syndrome (19), trisomy 18 (28), trisomy 13 (11) and others (14). Detection rate of combined screening for aneuploides were 86.0% with false positive rate of 5.3% (mean age 33±4.9 years, >35 years in 35% of pregnancies). Conclusion. Our study suggests that the strategy of first-trimester combined screening of biochemical values and ultrasonographic parameters at 12 gestational weeks identifies higher percentage of aneuploidies with a lower false-positive rate than a single parameter strategy.
机译:介绍。非整倍体是围产期死亡和早期心理生理疾病的主要原因。目的。在这项研究中,我们结合孕产妇年龄,胎儿颈部半透明(NT)厚度和孕产妇血清游离β-人绒毛膜促性腺激素(β-hCG),分析了孕早期非整倍性筛查的检测率和假阳性率,以及使用胎儿医学基金会开发的适当软件,在妊娠11-13 + 6周时与妊娠相关的血浆蛋白A(PAPP-A)。方法。我们对非整倍体的筛选研究分析了2006年1月至2010年12月的4172例单胎妊娠。使用非整倍体联合测定方法确定的风险临界值为1:275,评估了敏感性和假阳性率。结果。在21三体妊娠中,胎儿NT高于95%,为72.8%,无血清b-hCG浓度为55%,高于95%,PAPP-A低于5%,为47%。 。在18三体和13三体中,分别在66.6%和44.4%的病例中胎儿NT高于95位。血清游离b-hCG浓度在0%和10%时高于第95个百分位数,但在孕妇中80.9%和88.8%的血清PAPP-A低于第5个百分位。在21三体妊娠中,游离β-hCG的中位数为2.3 MoM,而PAPP-A的中位数为0.45 MoM。在169例胎儿中检测到染色体异常:21号三体(97),Turner综合征(19),18号三体(28),13号三体(11)和其他(14)。联合检查对中性神经节虫病的检出率为86.0%,假阳性率为5.3%(平均年龄33±4.9岁,在35%的孕妇中> 35岁)。结论。我们的研究表明,在妊娠第12周的孕早期联合筛查生化值和超声检查参数的策略比单参数策略能识别出更高的非整倍体百分比和更低的假阳性率。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号